NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nkarta, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.75−0.05 (-2.78%)
Close on Oct 19, 2026
- Market cap
- $130.37M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Nkarta statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Nkarta | Industry median |
|---|---|---|
| Market Cap | $125.34M | $166.30M |
| Enterprise Value | -$57.42M | $88.19M |
| PB Ratio | 0.51 | 2.03 |
| P/TBV Ratio | 0.51 | 2.29 |
Income (trailing twelve months)
| Measure | Nkarta | Industry median |
|---|---|---|
| Operating Income | -$132.25M | -$21.40M |
| Net Income | -$117.32M | -$22.46M |
| EBITDA | -$122.65M | -$16.91M |
| EPS (Diluted) | -$1.57 | -$0.83 |
Returns
| Measure | Nkarta | Industry median |
|---|---|---|
| Return on Equity (ROE) | -38.8% | -53.2% |
| Return on Assets (ROA) | -29.9% | -40.9% |
| Return on Invested Capital (ROIC) | -157.2% | -32.4% |
| Return on Capital Employed (ROCE) | -42.1% | -38.1% |
Balance sheet
| Measure | Nkarta | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $182.76M | $61.43M |
| Net Cash (Debt) | $182.76M | $15.35M |
| Net Cash Per Share | $2.55 | $0.66 |
| Equity (Book Value) | $247.74M | $49.09M |
| Book Value Per Share | $3.46 | $1.37 |
| Tangible Book Value | $247.74M | $23.52M |
| Working Capital | $164.48M | $76.81M |
Financial position
| Measure | Nkarta | Industry median |
|---|---|---|
| Current Ratio | 7.98 | 3.34 |
| Quick Ratio | 7.76 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Nkarta | Industry median |
|---|---|---|
| Operating Cash Flow | -$92.76M | -$12.35M |
| Capital Expenditures | -$1.15M | -$1.08M |
| Free Cash Flow | -$93.90M | -$20.22M |
| FCF Per Share | -$1.31 | -$0.42 |
Efficiency
| Measure | Nkarta | Industry median |
|---|---|---|
| Profits Per Employee | -$1.09M | -$703.34K |
| Employee Count | 108 | 74 |
Dividends and yields
| Measure | Nkarta | Industry median |
|---|---|---|
| Earnings Yield | -93.6% | -23.3% |
| FCF Yield | -74.9% | -8.72% |
| Dividend Yield | 0.00% | 1.82% |
| Shareholder Yield | 0.00% | 0.00% |
| Dividend Per Share | $0.00 | $0.83 |
| Years of Dividend Growth | 0 | 0 |
Shares
| Measure | Nkarta | Industry median |
|---|---|---|
| Shares Outstanding | 71,624,800 | 58,127,000 |
| Shares Change (YoY) | 0.59% | 10.9% |
| Float | 45,996,100 | 49,136,700 |
| Shares Held by Insiders | 35.8% | 11.6% |
| Shares Held by Institutions | 82.9% | 59.4% |
Taxes
| Measure | Nkarta | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Nkarta | Industry median |
|---|---|---|
| Altman Z-Score | -2.84 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Nkarta's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.